Relative contributions of stromal interaction molecule 1 and CalDAG-GEFI to calcium-dependent platelet activation and

F Ahmad1, Y Boulaftali, T K Greene

  • 1Department of Medicine and Cardeza Foundation for Hematologic Research, Thomas Jefferson University, Philadelphia, PA, USA.

Insights

Stromal interaction molecule 1 (STIM1) and CalDAG-GEFI are crucial for platelet procoagulant activity and thrombin generation. STIM1/SOCE is vital for platelet procoagulant function, while CalDAG-GEFI is essential for platelet aggregation.

Area of Science:

  • Hematology
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Stromal interaction molecule 1 (STIM1) is a key regulator of store-operated calcium entry (SOCE) in platelets.
  • CalDAG-GEFI, a Ca(2+)-sensing guanine nucleotide exchange factor, is critical for platelet Ca(2+) signaling.

Purpose of the Study:

  • To compare the roles of STIM1/SOCE and CalDAG-GEFI in platelet activation and thrombosis.
  • To elucidate the distinct contributions of STIM1 and CalDAG-GEFI to platelet function.

Main Methods:

  • Conditional deletion of the murine Stim1 gene in megakaryocytes/platelets.
  • Utilized CalDAG-GEFI(-/-) and Stim1(fl/fl) PF4-Cre mice for in vitro and in vivo studies.
  • Assessed platelet responses under static and flow conditions, including aggregation, phosphatidylserine exposure, and thrombosis models.

Main Results:

  • CalDAG-GEFI deficiency markedly impaired integrin α(IIb)β(3)-mediated aggregation, unlike STIM1 deficiency.
  • Both STIM1 and CalDAG-GEFI deficiency significantly reduced phosphatidylserine exposure on platelets.
  • STIM1-deficient platelets formed unstable thrombi with delayed fibrin generation; CalDAG-GEFI deficiency abolished platelet accumulation and reduced fibrin generation.

Conclusions:

  • STIM1/SOCE is essential for platelet procoagulant activity but not proadhesive function.
  • STIM1 and CalDAG-GEFI are critical for initial thrombin generation by procoagulant platelets at vascular injury sites.
Abstract

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...